UPDATE : Friday, October 18, 2019
상단여백
Helixmith blames hospital for absurd drug mix-up
Helixmith used to be one of the promising biotech firms with its market cap...
by Jeong Sae-im  |  2019-09-25 13:42
라인
NCC develops new chemotherapy to increase survival of osteosarcoma patients
A research team at the National Cancer Center has developed new chemotherap...
by Lee Han-soo  |  2019-09-25 11:48
라인
Court rejects Kolon’s appeal over Invossa license revocation
A Seoul court turned down Kolon Life Science’s appeal for stopping the gove...
by Jeong Sae-im  |  2019-09-25 11:18
라인
Huons, Lipac Oncology to co-develop bladder cancer treatment
Huons said that it has signed an exclusive licensing agreement for developi...
by Lee Han-soo  |  2019-09-25 11:18
라인
AstraZeneca releases detailed results of P3 trial of SGLT2 inhibitor
AstraZeneca announced detailed results of the landmark phase 3 DAPA-HF tria...
by Lee Han-soo  |  2019-09-24 18:08
라인
Qurient enrolls patients for trials of atopy treatment
Qurient said Tuesday that it has completed patient enrollment for phase 2b ...
by Lee Han-soo  |  2019-09-24 17:00
라인
Hanmi’s US partner to unveil results of anticancer drug study
Hanmi Pharmaceutical said that Athenex, its U.S. partner, plans to present ...
by Lee Han-soo  |  2019-09-24 17:00
라인
Thyroidectomy ups depression risk by 1.81 folds within 2 months
Patients who undergo thyroidectomy face a steep increase in depression risk...
by Kim Eun-young  |  2019-09-24 17:00
라인
Why using end-to-end services should be part of a drug product strategy
Specialized services offered by end-to-end service providers are essential ...
by Lee Han-soo  |  2019-09-24 16:54
라인
Helixmith's fails to end P3 trials of diabetic peripheral neuropathy treatment
Helixmith said that it has failed to make conclusions due to data contamina...
by Lee Han-soo  |  2019-09-24 16:38
라인
KMA advises doctors to avoid ranitidine in heartburn treatment
After the U.S. regulator found potentially cancer-causing chemical N-Nitros...
by Choi Gwang-seok  |  2019-09-24 14:40
라인
How does GE Healthcare use AI for product development?
GE Healthcare drew keen attention by unveiling Edison, an intelligence plat...
by Park Gi-taek  |  2019-09-24 12:42
라인
Dog dewormer gets scarce amid rumors of efficacy in cancer
Korean cancer patients are rushing to pharmacies to buy fenbendazole, a dog...
by Lee Han-soo  |  2019-09-24 12:41
라인
Hwail, SupexBNP wins patent for neutropenia treatment in US
Hwail Pharmaceutical and SupexBNP said that they have registered a patent f...
by Lee Han-soo  |  2019-09-23 22:34
라인
Ministry advises smokers to stop using e-cigarettes
The Ministry of Health and Welfare has recommended smokers who use e-cigare...
by Lee Han-soo  |  2019-09-23 16:55
라인
FDA recommends Kolon to remanufacture Invossa’s second fluid
The U.S. Food and Drug Administration has recommended Kolon TissueGene to r...
by Jeong Sae-im  |  2019-09-23 15:32
라인
Dong-A ST's Aranesp biosimilar gets nod in Japan
Dong-A ST said that Sanwa Kagaku Kenkyusho (SKK), its Japanese partner, has...
by Lee Han-soo  |  2019-09-23 15:31
라인
Drug firms uncertain about pricing of quadrivalent flu vaccines
As the 2019-2020 flu season approaches, pharmaceutical firms are engaging i...
by Jeong Sae-im  |  2019-09-23 14:52
라인
Vuno, Daegu Fatima Hospital to cooperate on AI-based medical service
Vuno said that it would collaborate with Daegu Fatima Hospital to establish...
by Lee Han-soo  |  2019-09-23 14:52
라인
Roche’s Tecentriq becomes 1st immunotherapy to win indication for SCLC
Roche Korea has received approval from the Ministry of Food and Drug Safety...
by Lee Han-soo  |  2019-09-23 13:28
여백
여백
여백
Back to Top